首页 > 最新文献

BMC Cardiovascular Disorders最新文献

英文 中文
Strain echocardiography predictors in patients with concomitant cardiac amyloidosis and aortic stenosis: a cross-sectional study. 应变超声心动图预测合并心脏淀粉样变性和主动脉瓣狭窄的患者:一项横断面研究。
IF 2 3区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-12-20 DOI: 10.1186/s12872-024-04415-8
Samira Jafarisis, Shahab Masoumi, Naser Khezerlouy-Aghdam, Kia Seyed Toutounchi, Amirreza Jabbaripour Sarmadian, Sina Hamzehzadeh, Akram Shariati, Razieh Parizad, Venus Shahabi Rabori

Background: Concomitant cardiac amyloidosis (CA) and aortic stenosis (AS) may be mistaken for isolated AS, potentially impacting the treatment strategy and patient's prognosis. Therefore, it is crucial to distinguish between these conditions, as failure to promptly diagnose CA may lead to considerable complications. The aim of this study is to investigate the diagnostic value of strain predictors in patients with concomitant CA and AS compared to isolated AS.

Methods: Forty-two patients with severe AS suspected of concomitant CA based on a comprehensive clinical evaluation were selected to undergo 99mTc-DPD scintigraphy. Those showing Perugini grade 2 or 3 tracer uptakes without evidence of monoclonal gammopathy were diagnosed with CA and underwent speckle-tracking echocardiography. Furthermore, strain analysis was performed to evaluate myocardial deformation, with a focus on detecting apical sparing and reduction in bull's eye mapping, resulting in the characteristic "cherry on top" sign.

Results: Eight patients were diagnosed with CA, representing 19.0% of those suspected of concomitant CA and 7.8% of the overall cohort with severe AS. AF arrhythmia was significantly more frequent in these patients compared to those with isolated AS. Echocardiography findings revealed that E/E' ratio and RALS were significantly higher in patients with concomitant CA, while GLS and mean basal LS were significantly lower in this group. The "cherry on top" sign was detected in 19 patients (45.2%), present in 100% of those with concomitant CA and AS, versus 32.4% in isolated AS cases (P = 0.04). This sign demonstrated a sensitivity of 100% and a specificity of 67.6% for predicting concomitant CA and AS.

Conclusions: In conclusion, the "cherry on top" sign was significantly more prevalent in patients with concomitant CA and AS, compared to those with isolated AS, demonstrating a sensitivity of 100% and a specificity of 67.6% for predicting concomitant CA. Moreover, RALS and E/E' ratios were significantly higher in patients with concomitant CA, whereas GLS and mean basal LS were significantly lower in this group.

背景:合并心脏淀粉样变性(CA)和主动脉瓣狭窄(AS)可能被误认为是孤立性AS,可能影响治疗策略和患者预后。因此,区分这些疾病是至关重要的,因为不能及时诊断CA可能会导致相当多的并发症。本研究的目的是探讨菌株预测因子对合并CA和AS患者的诊断价值,并与单独的AS进行比较。方法:选择42例经临床综合评价怀疑合并CA的严重AS患者行99mTc-DPD显像。那些显示Perugini 2级或3级示踪剂摄取而无单克隆伽玛病证据的患者被诊断为CA,并接受斑点跟踪超声心动图检查。此外,进行应变分析以评估心肌变形,重点是检测心尖保留和牛眼图减少,从而产生典型的“樱桃顶”标志。结果:8例患者被诊断为CA,占疑似合并CA患者的19.0%,占严重AS患者的7.8%。与孤立性AS患者相比,这些患者的心律失常明显更频繁。超声心动图结果显示,合并CA患者的E/E′比和RALS均显著升高,而GLS和平均基础LS均显著降低。在19例患者(45.2%)中检测到“顶部的樱桃”标志,100%伴有CA和AS的患者存在,而在单独的AS病例中为32.4% (P = 0.04)。该征象预测CA和AS合并的敏感性为100%,特异性为67.6%。结论:与单纯AS患者相比,合并CA和AS患者的“樱桃顶”体征明显更普遍,预测合并CA的敏感性为100%,特异性为67.6%。此外,合并CA患者的RALS和E/E’比值显著较高,而GLS和平均基础LS显著较低。
{"title":"Strain echocardiography predictors in patients with concomitant cardiac amyloidosis and aortic stenosis: a cross-sectional study.","authors":"Samira Jafarisis, Shahab Masoumi, Naser Khezerlouy-Aghdam, Kia Seyed Toutounchi, Amirreza Jabbaripour Sarmadian, Sina Hamzehzadeh, Akram Shariati, Razieh Parizad, Venus Shahabi Rabori","doi":"10.1186/s12872-024-04415-8","DOIUrl":"10.1186/s12872-024-04415-8","url":null,"abstract":"<p><strong>Background: </strong>Concomitant cardiac amyloidosis (CA) and aortic stenosis (AS) may be mistaken for isolated AS, potentially impacting the treatment strategy and patient's prognosis. Therefore, it is crucial to distinguish between these conditions, as failure to promptly diagnose CA may lead to considerable complications. The aim of this study is to investigate the diagnostic value of strain predictors in patients with concomitant CA and AS compared to isolated AS.</p><p><strong>Methods: </strong>Forty-two patients with severe AS suspected of concomitant CA based on a comprehensive clinical evaluation were selected to undergo <sup>99</sup>mTc-DPD scintigraphy. Those showing Perugini grade 2 or 3 tracer uptakes without evidence of monoclonal gammopathy were diagnosed with CA and underwent speckle-tracking echocardiography. Furthermore, strain analysis was performed to evaluate myocardial deformation, with a focus on detecting apical sparing and reduction in bull's eye mapping, resulting in the characteristic \"cherry on top\" sign.</p><p><strong>Results: </strong>Eight patients were diagnosed with CA, representing 19.0% of those suspected of concomitant CA and 7.8% of the overall cohort with severe AS. AF arrhythmia was significantly more frequent in these patients compared to those with isolated AS. Echocardiography findings revealed that E/E' ratio and RALS were significantly higher in patients with concomitant CA, while GLS and mean basal LS were significantly lower in this group. The \"cherry on top\" sign was detected in 19 patients (45.2%), present in 100% of those with concomitant CA and AS, versus 32.4% in isolated AS cases (P = 0.04). This sign demonstrated a sensitivity of 100% and a specificity of 67.6% for predicting concomitant CA and AS.</p><p><strong>Conclusions: </strong>In conclusion, the \"cherry on top\" sign was significantly more prevalent in patients with concomitant CA and AS, compared to those with isolated AS, demonstrating a sensitivity of 100% and a specificity of 67.6% for predicting concomitant CA. Moreover, RALS and E/E' ratios were significantly higher in patients with concomitant CA, whereas GLS and mean basal LS were significantly lower in this group.</p>","PeriodicalId":9195,"journal":{"name":"BMC Cardiovascular Disorders","volume":"24 1","pages":"734"},"PeriodicalIF":2.0,"publicationDate":"2024-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11660616/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142871258","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Baicalin improves isoproterenol-induced cardiac remodeling by regulating the Nrf2-dependent signaling pathway. 黄芩苷通过调节nrf2依赖性信号通路改善异丙肾上腺素诱导的心脏重构。
IF 2 3区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-12-20 DOI: 10.1186/s12872-024-04395-9
Kai Qian, Li Song, Jia-Min Guo, Dan Fu, Jia Shi, Yu Ma, Zi-Jie Ge, Lei Li, Su-Qin Zhang

Background: Cardiovascular disease carries the highest mortality rate among diseases, and pharmacological interventions have limited efficacy. Baicalin (Bai) promotes biological metabolic processes, eliminates oxygen free radicals, and is anti-inflammatory. This study aimed to investigate the effect of Bai on the cardiac injury model induced by isoproterenol in mice.

Methods and result: In this study, all groups except the control received intraperitoneal injections of isoproterenol (ISO) to induce a cardiac injury model, with the drug administered continuously for 14 days. hematoxylin and eosin staining and Masson's trichrome staining revealed that Bai significantly mitigated ISO-induced pathological changes in mouse heart tissue and alleviated myocardial hypertrophy. Echocardiography assessments demonstrated that Bai preserved cardiac function in ISO-treated mice. Furthermore, our findings indicated that Bai activated the Nrf2 signaling pathway in vivo and in vitro. To delve deeper, mice were further treated with ML385 (ML) via intraperitoneal injection to inhibit the Nrf2 pathway. Results showed that ML385 blocked the cardioprotective effects of Bai in mouse heart tissue.

Conclusion: Bai protects against ISO-induced cardiac injury, and its mechanism is related to activating the Nrf2/HO-1 signaling pathway to regulate cardiac ferroptosis and improve cardiac remodeling.

背景:心血管疾病是疾病中死亡率最高的疾病,药物干预效果有限。黄芩苷(Bai)促进生物代谢过程,消除氧自由基,具有抗炎作用。本研究旨在探讨白芍对异丙肾上腺素致小鼠心脏损伤模型的影响。方法与结果:本研究除对照组外,其余各组大鼠均腹腔注射异丙肾上腺素(ISO)建立心脏损伤模型,连续给药14 d。苏木精和伊红染色及马松三色染色显示,白可明显减轻iso诱导的小鼠心脏组织病理改变,减轻心肌肥厚。超声心动图评估显示,白保留了iso处理小鼠的心脏功能。此外,我们的研究结果表明,Bai在体内和体外都激活了Nrf2信号通路。为了深入研究,我们进一步通过腹腔注射ML385 (ML)对小鼠进行处理,以抑制Nrf2通路。结果表明,ML385可阻断白对小鼠心脏组织的保护作用。结论:白对iso诱导的心脏损伤具有保护作用,其机制可能与激活Nrf2/HO-1信号通路调节心脏铁下沉、改善心脏重构有关。
{"title":"Baicalin improves isoproterenol-induced cardiac remodeling by regulating the Nrf2-dependent signaling pathway.","authors":"Kai Qian, Li Song, Jia-Min Guo, Dan Fu, Jia Shi, Yu Ma, Zi-Jie Ge, Lei Li, Su-Qin Zhang","doi":"10.1186/s12872-024-04395-9","DOIUrl":"10.1186/s12872-024-04395-9","url":null,"abstract":"<p><strong>Background: </strong>Cardiovascular disease carries the highest mortality rate among diseases, and pharmacological interventions have limited efficacy. Baicalin (Bai) promotes biological metabolic processes, eliminates oxygen free radicals, and is anti-inflammatory. This study aimed to investigate the effect of Bai on the cardiac injury model induced by isoproterenol in mice.</p><p><strong>Methods and result: </strong>In this study, all groups except the control received intraperitoneal injections of isoproterenol (ISO) to induce a cardiac injury model, with the drug administered continuously for 14 days. hematoxylin and eosin staining and Masson's trichrome staining revealed that Bai significantly mitigated ISO-induced pathological changes in mouse heart tissue and alleviated myocardial hypertrophy. Echocardiography assessments demonstrated that Bai preserved cardiac function in ISO-treated mice. Furthermore, our findings indicated that Bai activated the Nrf2 signaling pathway in vivo and in vitro. To delve deeper, mice were further treated with ML385 (ML) via intraperitoneal injection to inhibit the Nrf2 pathway. Results showed that ML385 blocked the cardioprotective effects of Bai in mouse heart tissue.</p><p><strong>Conclusion: </strong>Bai protects against ISO-induced cardiac injury, and its mechanism is related to activating the Nrf2/HO-1 signaling pathway to regulate cardiac ferroptosis and improve cardiac remodeling.</p>","PeriodicalId":9195,"journal":{"name":"BMC Cardiovascular Disorders","volume":"24 1","pages":"733"},"PeriodicalIF":2.0,"publicationDate":"2024-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11660785/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142871442","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Using artificial intelligence to predict post-operative outcomes in congenital heart surgeries: a systematic review. 利用人工智能预测先天性心脏病手术的术后效果:系统综述。
IF 2 3区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-12-20 DOI: 10.1186/s12872-024-04336-6
Ida Mohammadi, Shahryar Rajai Firouzabadi, Melika Hosseinpour, Mohammadhosein Akhlaghpasand, Bardia Hajikarimloo, Sam Zeraatian-Nejad, Peyman Sardari Nia

Introduction: Congenital heart disease (CHD) represents the most common group of congenital anomalies, constitutes a significant contributor to the burden of non-communicable diseases, highlighting the critical need for improved risk assessment tools. Artificial intelligence (AI) holds promise in enhancing outcome predictions for congenital cardiac surgery. This study aims to systematically review the utilization of AI in predicting post-operative outcomes in this population.

Methods: Following PRISMA guidelines, a comprehensive search of Pubmed, Scopus, and Web of Science databases was conducted. Two independent reviewers screened articles based on predefined criteria. Included studies focused on AI models predicting various post-operative outcomes in congenital heart surgery.

Results: The review included 35 articles, primarily published within the last four years, indicating growing interest in AI applications. Models predominantly targeted mortality and survival (n = 16), prolonged length of hospital or ICU stay (n = 7), postoperative complications (n = 6), prolonged mechanical ventilatory support time (n = 4), with additional focus on specific outcomes such as peri-ventricular leucomalacia (n = 2) and malnutrition (n = 1). Performance metrics, such as area under the curve (AUC), ranged from 0.52 to 0.997. Notably, these AI models consistently outperformed traditional risk stratification categories. For instance, in assessing the risk of morbidity and mortality, the AI models demonstrated superior performance compared to conventional methods.

Conclusion: AI-driven prediction models show significant promise in improving outcome predictions for congenital heart surgery. They surpass traditional risk prediction tools not only in immediate postoperative risks but also in long-term outcomes such as 1-year survival and malnutrition. Further studies with robust external validation are necessary to assess the practical applicability of these models in clinical settings. The protocol of this review was prospectively registered on PROSPERO (CRD42024550942).

导言:先天性心脏病(CHD)是最常见的先天性异常,是造成非传染性疾病负担的一个重要因素,突出表明亟需改进风险评估工具。人工智能(AI)有望提高先天性心脏手术的预后预测。本研究旨在系统回顾人工智能在预测该人群术后预后方面的应用。方法:按照PRISMA指南,对Pubmed、Scopus和Web of Science数据库进行综合检索。两名独立审稿人根据预先确定的标准筛选文章。包括人工智能模型预测先天性心脏手术各种术后结果的研究。结果:该综述包括35篇文章,主要发表于过去四年,表明人们对人工智能应用的兴趣日益浓厚。模型主要针对死亡率和生存率(n = 16)、住院或ICU住院时间延长(n = 7)、术后并发症(n = 6)、机械通气支持时间延长(n = 4),并额外关注特定结果,如心室周围白质软化(n = 2)和营养不良(n = 1)。性能指标,如曲线下面积(AUC),范围从0.52到0.997。值得注意的是,这些人工智能模型的表现始终优于传统的风险分层类别。例如,在评估发病率和死亡率的风险方面,与传统方法相比,人工智能模型表现出了优越的性能。结论:人工智能驱动的预测模型在改善先天性心脏手术预后预测方面显示出显著的前景。它们不仅在术后即时风险方面优于传统的风险预测工具,而且在1年生存率和营养不良等长期结果方面也优于传统的风险预测工具。需要进一步的研究与强大的外部验证来评估这些模型在临床环境中的实际适用性。本综述的方案在PROSPERO上前瞻性注册(CRD42024550942)。
{"title":"Using artificial intelligence to predict post-operative outcomes in congenital heart surgeries: a systematic review.","authors":"Ida Mohammadi, Shahryar Rajai Firouzabadi, Melika Hosseinpour, Mohammadhosein Akhlaghpasand, Bardia Hajikarimloo, Sam Zeraatian-Nejad, Peyman Sardari Nia","doi":"10.1186/s12872-024-04336-6","DOIUrl":"10.1186/s12872-024-04336-6","url":null,"abstract":"<p><strong>Introduction: </strong>Congenital heart disease (CHD) represents the most common group of congenital anomalies, constitutes a significant contributor to the burden of non-communicable diseases, highlighting the critical need for improved risk assessment tools. Artificial intelligence (AI) holds promise in enhancing outcome predictions for congenital cardiac surgery. This study aims to systematically review the utilization of AI in predicting post-operative outcomes in this population.</p><p><strong>Methods: </strong>Following PRISMA guidelines, a comprehensive search of Pubmed, Scopus, and Web of Science databases was conducted. Two independent reviewers screened articles based on predefined criteria. Included studies focused on AI models predicting various post-operative outcomes in congenital heart surgery.</p><p><strong>Results: </strong>The review included 35 articles, primarily published within the last four years, indicating growing interest in AI applications. Models predominantly targeted mortality and survival (n = 16), prolonged length of hospital or ICU stay (n = 7), postoperative complications (n = 6), prolonged mechanical ventilatory support time (n = 4), with additional focus on specific outcomes such as peri-ventricular leucomalacia (n = 2) and malnutrition (n = 1). Performance metrics, such as area under the curve (AUC), ranged from 0.52 to 0.997. Notably, these AI models consistently outperformed traditional risk stratification categories. For instance, in assessing the risk of morbidity and mortality, the AI models demonstrated superior performance compared to conventional methods.</p><p><strong>Conclusion: </strong>AI-driven prediction models show significant promise in improving outcome predictions for congenital heart surgery. They surpass traditional risk prediction tools not only in immediate postoperative risks but also in long-term outcomes such as 1-year survival and malnutrition. Further studies with robust external validation are necessary to assess the practical applicability of these models in clinical settings. The protocol of this review was prospectively registered on PROSPERO (CRD42024550942).</p>","PeriodicalId":9195,"journal":{"name":"BMC Cardiovascular Disorders","volume":"24 1","pages":"718"},"PeriodicalIF":2.0,"publicationDate":"2024-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11660586/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142863225","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Blood flow dynamics in the ascending aorta of patients with bicuspid aortic valve before and after transcatheter aortic valve replacement: a computational fluid dynamics study. 经导管主动脉瓣置换术前后二尖瓣患者升主动脉的血流动力学:计算流体动力学研究。
IF 2 3区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-12-20 DOI: 10.1186/s12872-024-04394-w
Kang An, Fengwen Zhang, Wenbin Ouyang, Xiangbin Pan

Background: Abnormal blood flow patterns are known to contribute to the ascending aortic dilation in patients with bicuspid aortic valve (BAV). The present study elucidated the blood flow characteristics in the dilated ascending aorta before and after transcatheter aortic valve replacement (TAVR) using computational fluid dynamics (CFD) analysis.

Methods: We performed CFD analysis in three BAV patients with ascending aortic dilation (maximum diameter ≥ 45 mm) who underwent TAVR. The blood flow streamline was visualized to evaluate the pre- and post-operative flow velocity, severity of vortex and helix, and wall shear stress (WSS) in the ascending aorta.

Results: Before the procedure, all three patients showed abnormal blood flow patterns, with vortex and helix in the ascending aorta. Regionally elevated WSS was also observed in the lateral or posterior ascending aortic wall (16.7 Pa, 12.2 Pa, and 14.5 Pa in patient 1, 2, and 3, respectively). After the procedure, the blood flow patterns significantly improved, and the maximum WSS also decreased (4.2 Pa, 1.1 Pa, and 3.2 Pa in patient 1, 2, and 3, respectively).

Conclusion: Abnormal blood flow patterns and WSS appeared to improve after TAVR in BAV patients with ascending aortic dilation. The impact on the long-term aortic growth rate and the incidence of aortic dissection requires further studies.

Trial registration: Changes of Ascending Aortic Diameter in Patients Undergoing Transcatheter Aortic Valve Replacement.

Clinicaltrial: gov number NCT05739253. Trial registration date 20,230,212.

背景:已知异常血流模式可导致双尖瓣主动脉瓣(BAV)患者的升主动脉扩张。本研究利用计算流体动力学(CFD)分析了经导管主动脉瓣置换术(TAVR)前后扩张的升主动脉血流特性。方法:我们对3例升主动脉扩张(最大直径≥45mm)行TAVR的BAV患者进行CFD分析。观察血流流线,评估术前、术后升主动脉血流速度、漩涡、螺旋严重程度及壁剪切应力(WSS)。结果:术前3例患者均表现为升主动脉漩涡型、螺旋型血流异常。在升主动脉壁外侧或后壁也观察到区域性WSS升高(患者1、2和3分别为16.7 Pa、12.2 Pa和14.5 Pa)。手术后,血流模式明显改善,最大WSS也下降(患者1、2和3分别为4.2 Pa、1.1 Pa和3.2 Pa)。结论:BAV升主动脉扩张患者经TAVR后血流量异常及WSS均有改善。对主动脉长期生长速率和主动脉夹层发生率的影响有待进一步研究。试验注册:经导管主动脉瓣置换术患者升主动脉直径的变化。临床试验:政府编号NCT05739253。试验注册日期为20,230,212。
{"title":"Blood flow dynamics in the ascending aorta of patients with bicuspid aortic valve before and after transcatheter aortic valve replacement: a computational fluid dynamics study.","authors":"Kang An, Fengwen Zhang, Wenbin Ouyang, Xiangbin Pan","doi":"10.1186/s12872-024-04394-w","DOIUrl":"10.1186/s12872-024-04394-w","url":null,"abstract":"<p><strong>Background: </strong>Abnormal blood flow patterns are known to contribute to the ascending aortic dilation in patients with bicuspid aortic valve (BAV). The present study elucidated the blood flow characteristics in the dilated ascending aorta before and after transcatheter aortic valve replacement (TAVR) using computational fluid dynamics (CFD) analysis.</p><p><strong>Methods: </strong>We performed CFD analysis in three BAV patients with ascending aortic dilation (maximum diameter ≥ 45 mm) who underwent TAVR. The blood flow streamline was visualized to evaluate the pre- and post-operative flow velocity, severity of vortex and helix, and wall shear stress (WSS) in the ascending aorta.</p><p><strong>Results: </strong>Before the procedure, all three patients showed abnormal blood flow patterns, with vortex and helix in the ascending aorta. Regionally elevated WSS was also observed in the lateral or posterior ascending aortic wall (16.7 Pa, 12.2 Pa, and 14.5 Pa in patient 1, 2, and 3, respectively). After the procedure, the blood flow patterns significantly improved, and the maximum WSS also decreased (4.2 Pa, 1.1 Pa, and 3.2 Pa in patient 1, 2, and 3, respectively).</p><p><strong>Conclusion: </strong>Abnormal blood flow patterns and WSS appeared to improve after TAVR in BAV patients with ascending aortic dilation. The impact on the long-term aortic growth rate and the incidence of aortic dissection requires further studies.</p><p><strong>Trial registration: </strong>Changes of Ascending Aortic Diameter in Patients Undergoing Transcatheter Aortic Valve Replacement.</p><p><strong>Clinicaltrial: </strong>gov number NCT05739253. Trial registration date 20,230,212.</p>","PeriodicalId":9195,"journal":{"name":"BMC Cardiovascular Disorders","volume":"24 1","pages":"717"},"PeriodicalIF":2.0,"publicationDate":"2024-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11660676/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142863425","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Global burden of myocarditis from 1990 to 2021: findings from the Global Burden of Disease Study 2021. 1990 年至 2021 年心肌炎的全球负担:2021 年全球疾病负担研究的结果。
IF 2 3区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-12-20 DOI: 10.1186/s12872-024-04402-z
Jiahui Li, Hongxuan Fan, Yafen Yang, Zhuolin Huang, Yalin Yuan, Bin Liang

Background: Myocarditis is a major public health, social, and economic issue. Currently, few studies have provided comprehensive analyses of the global burden of myocarditis based on GBD (Global Burden Disease) 2021. We therefore analyzed long-term trends in the global burden of myocarditis from 1990 to 2021, described risk factors, examined the impact of COVID-19 (coronavirus infection disease 2019), and predicted future trends to inform health policy development and healthcare resource allocation.

Method: From the GBD 2021 database, incident cases, deaths, and DALYs (disability-adjusted life years) were obtained for countries, regions, ages, and sexes globally. The estimated annual percentage change (EAPC) was used to analyze Trends in age-standardized rates of myocarditis and significant time points were examined using joinpoint regression analysis.

Results: Globally, the age-standardized incidence rate (ASIR), DALYs rate (ASDALYsR), and death rate (ASDR) for myocarditis in 2021 were 16.16 [(13.11 to 19.76) per 100 000 people], 12.41 [10.37 to 14.76) per 100 000 people], and 0.40 [0.32 to 0.47) per 100 000 people], respectively. High-income Asia Pacific had the highest myocarditis ASIR in 2021, whereas Central Europe had the highest ASDALYsR and ASDR. Gender comparison showed myocarditis was more common in men. The burden of myocarditis was larger in the elderly aged 80 and older, but children should not be neglected. Analysis revealed a rise in worldwide ASIR from 2016 to 2021 (APC = 0.0945, 95%CI: 0.0709 to 0.1440, p < 0.001). During COVID-19, myocarditis burden did not peak. Both high and low temperatures increase myocarditis risk. The Bayesian age-period-cohort (BAPC) model predicted that myocarditis ASIR would rise while ASDALYsR and ASDR would decrease.

Conclusions: The global burden of myocarditis remains a health issue that cannot be ignored and shows significant regional and sex-based differences. Effective and targeted strategies for the prevention and management of myocarditis in this population are needed to reduce the overall burden.

Clinical trial number: Not applicable.

背景:心肌炎是一个重大的公共卫生、社会和经济问题。目前,很少有研究基于GBD (global burden Disease) 2021对全球心肌炎负担进行全面分析。因此,我们分析了1990年至2021年全球心肌炎负担的长期趋势,描述了危险因素,检查了COVID-19(2019冠状病毒感染疾病)的影响,并预测了未来趋势,为卫生政策制定和医疗资源分配提供信息。方法:从GBD 2021数据库中获取全球国家、地区、年龄和性别的事件病例、死亡和DALYs(残疾调整生命年)。估计年百分比变化(EAPC)用于分析年龄标准化心肌炎发病率的趋势,并使用联合点回归分析检查显著时间点。结果:全球范围内,2021年心肌炎的年龄标准化发病率(ASIR)、DALYs率(ASDALYsR)和死亡率(ASDR)分别为16.16[(13.11 ~ 19.76)/ 10万人]、12.41[10.37 ~ 14.76)/ 10万人]和0.40[0.32 ~ 0.47)/ 10万人。高收入亚太地区在2021年的心肌炎ASIR最高,而中欧的ASDALYsR和ASDR最高。性别比较显示心肌炎以男性多见。80岁及以上的老年人心肌炎负担较大,但儿童也不容忽视。分析显示,从2016年到2021年,全球ASIR上升(APC = 0.0945, 95%CI: 0.0709至0.1440,p)。结论:全球心肌炎负担仍然是一个不容忽视的健康问题,并表现出显著的地区和性别差异。需要有效和有针对性的策略来预防和管理这一人群的心肌炎,以减轻总体负担。临床试验号:不适用。
{"title":"Global burden of myocarditis from 1990 to 2021: findings from the Global Burden of Disease Study 2021.","authors":"Jiahui Li, Hongxuan Fan, Yafen Yang, Zhuolin Huang, Yalin Yuan, Bin Liang","doi":"10.1186/s12872-024-04402-z","DOIUrl":"10.1186/s12872-024-04402-z","url":null,"abstract":"<p><strong>Background: </strong>Myocarditis is a major public health, social, and economic issue. Currently, few studies have provided comprehensive analyses of the global burden of myocarditis based on GBD (Global Burden Disease) 2021. We therefore analyzed long-term trends in the global burden of myocarditis from 1990 to 2021, described risk factors, examined the impact of COVID-19 (coronavirus infection disease 2019), and predicted future trends to inform health policy development and healthcare resource allocation.</p><p><strong>Method: </strong>From the GBD 2021 database, incident cases, deaths, and DALYs (disability-adjusted life years) were obtained for countries, regions, ages, and sexes globally. The estimated annual percentage change (EAPC) was used to analyze Trends in age-standardized rates of myocarditis and significant time points were examined using joinpoint regression analysis.</p><p><strong>Results: </strong>Globally, the age-standardized incidence rate (ASIR), DALYs rate (ASDALYsR), and death rate (ASDR) for myocarditis in 2021 were 16.16 [(13.11 to 19.76) per 100 000 people], 12.41 [10.37 to 14.76) per 100 000 people], and 0.40 [0.32 to 0.47) per 100 000 people], respectively. High-income Asia Pacific had the highest myocarditis ASIR in 2021, whereas Central Europe had the highest ASDALYsR and ASDR. Gender comparison showed myocarditis was more common in men. The burden of myocarditis was larger in the elderly aged 80 and older, but children should not be neglected. Analysis revealed a rise in worldwide ASIR from 2016 to 2021 (APC = 0.0945, 95%CI: 0.0709 to 0.1440, p < 0.001). During COVID-19, myocarditis burden did not peak. Both high and low temperatures increase myocarditis risk. The Bayesian age-period-cohort (BAPC) model predicted that myocarditis ASIR would rise while ASDALYsR and ASDR would decrease.</p><p><strong>Conclusions: </strong>The global burden of myocarditis remains a health issue that cannot be ignored and shows significant regional and sex-based differences. Effective and targeted strategies for the prevention and management of myocarditis in this population are needed to reduce the overall burden.</p><p><strong>Clinical trial number: </strong>Not applicable.</p>","PeriodicalId":9195,"journal":{"name":"BMC Cardiovascular Disorders","volume":"24 1","pages":"720"},"PeriodicalIF":2.0,"publicationDate":"2024-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11660449/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142863451","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Troponin-T as predictor of mortality in patients attending the emergency department with atrial fibrillation. 肌钙蛋白- t作为急诊科房颤患者死亡率的预测因子
IF 2 3区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-12-20 DOI: 10.1186/s12872-024-04388-8
Serkan Celik, Linus Bodeström Eriksson, Jakob Hytting, Annette Waldemar, Panagiotis Mallios, Amanda Berggren, Ellen Oscarsson, Christofer Digerfeldt, Magnus Wijkman, Laila Hubbert

Background: High-sensitive Troponin-T (hsTnT) is often increased in acute illness and may be of prognostic importance in patients with atrial fibrillation (AF). The aim of this study was to analyse the characteristics and data of patients attending the emergency department (ED) with AF to determine whether age-adjusted hsTnT levels can predict mortality.

Methods: This retrospective, single centre, register-based cohort study included all patients ≥ 18 years attending the emergency department during 2018 and 2020 with a primary diagnosis at the ED of AF and sampled for hsTnT. Symptoms, comorbidities, lab results, and characteristics were registered. Patients were divided into groups based on hsTnT level (< 15, 15-50, and > 50 ng/L).

Primary outcomes: 30-day and 1-year mortality.

Results: A total of 625 patients were included (median age 72, and 45% female). All-cause mortality was 2% at 30 days and 8% at 1-year. The hazard ratio (HR) for 30-day mortality was 4.17 (95% confidence interval (CI) 0.49-35.79, p = 0.192) for hsTnT 15-50 ng/L and 9.64 (95% CI 0.98-95.30, p = 0.053) for hsTnT > 50 ng/L compared to hsTnT < 15 ng/L when adjusted for age. The HR for 1-year mortality was 4.82 (95% CI 1.81-12.82, p = 0.002) for hsTnT 15-50 ng/L and 9.70 (95% CI 3.27-28.74, p < 0.001) for hsTnT > 50 ng/L compared to hsTnT < 15 ng/L when adjusted for age.

Conclusions: Elevated hsTnT levels increase the risk for 30-day and 1-year mortality independently of age. Both mild and major elevation of hsTnT levels is associated with increased risk for 1-year mortality regardless of age.

背景:高敏感性肌钙蛋白- t (hsTnT)在急性疾病中经常升高,可能对房颤(AF)患者的预后具有重要意义。本研究的目的是分析急诊科(ED)房颤患者的特征和数据,以确定年龄调整后的hsTnT水平是否可以预测死亡率。方法:这项回顾性、单中心、基于登记的队列研究纳入了2018年至2020年期间在急诊科就诊的所有≥18岁的患者,这些患者最初诊断为房颤的急诊科,并取样为hsTnT。记录了症状、合并症、实验室结果和特征。根据hsTnT水平(50 ng/L)进行分组。主要结局:30天和1年死亡率。结果:共纳入625例患者(中位年龄72岁,其中45%为女性)。30天全因死亡率为2%,1年死亡率为8%。hsTnT 15-50 ng/L患者30天死亡率的风险比(HR)为4.17(95%可信区间(CI) 0.49-35.79, p = 0.192), hsTnT 50 ng/L患者30天死亡率的风险比(HR)为9.64 (95% CI 0.98-95.30, p = 0.053)。结论:hsTnT水平升高会增加30天和1年死亡率的风险,与年龄无关。不论年龄大小,hsTnT水平的轻度和重度升高均与1年死亡风险增加相关。
{"title":"Troponin-T as predictor of mortality in patients attending the emergency department with atrial fibrillation.","authors":"Serkan Celik, Linus Bodeström Eriksson, Jakob Hytting, Annette Waldemar, Panagiotis Mallios, Amanda Berggren, Ellen Oscarsson, Christofer Digerfeldt, Magnus Wijkman, Laila Hubbert","doi":"10.1186/s12872-024-04388-8","DOIUrl":"10.1186/s12872-024-04388-8","url":null,"abstract":"<p><strong>Background: </strong>High-sensitive Troponin-T (hsTnT) is often increased in acute illness and may be of prognostic importance in patients with atrial fibrillation (AF). The aim of this study was to analyse the characteristics and data of patients attending the emergency department (ED) with AF to determine whether age-adjusted hsTnT levels can predict mortality.</p><p><strong>Methods: </strong>This retrospective, single centre, register-based cohort study included all patients ≥ 18 years attending the emergency department during 2018 and 2020 with a primary diagnosis at the ED of AF and sampled for hsTnT. Symptoms, comorbidities, lab results, and characteristics were registered. Patients were divided into groups based on hsTnT level (< 15, 15-50, and > 50 ng/L).</p><p><strong>Primary outcomes: </strong>30-day and 1-year mortality.</p><p><strong>Results: </strong>A total of 625 patients were included (median age 72, and 45% female). All-cause mortality was 2% at 30 days and 8% at 1-year. The hazard ratio (HR) for 30-day mortality was 4.17 (95% confidence interval (CI) 0.49-35.79, p = 0.192) for hsTnT 15-50 ng/L and 9.64 (95% CI 0.98-95.30, p = 0.053) for hsTnT > 50 ng/L compared to hsTnT < 15 ng/L when adjusted for age. The HR for 1-year mortality was 4.82 (95% CI 1.81-12.82, p = 0.002) for hsTnT 15-50 ng/L and 9.70 (95% CI 3.27-28.74, p < 0.001) for hsTnT > 50 ng/L compared to hsTnT < 15 ng/L when adjusted for age.</p><p><strong>Conclusions: </strong>Elevated hsTnT levels increase the risk for 30-day and 1-year mortality independently of age. Both mild and major elevation of hsTnT levels is associated with increased risk for 1-year mortality regardless of age.</p>","PeriodicalId":9195,"journal":{"name":"BMC Cardiovascular Disorders","volume":"24 1","pages":"719"},"PeriodicalIF":2.0,"publicationDate":"2024-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11660876/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142863209","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mid-term angiographic evaluation of LIMA-LAD anastomoses following LAD endarterectomy in coronary artery bypass grafting. 冠状动脉搭桥术中LAD动脉内膜切除术后LIMA-LAD吻合的中期血管造影评价。
IF 2 3区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-12-20 DOI: 10.1186/s12872-024-04416-7
Farida Zahirova, Çiğdem Tel Üstünışık, Berk Arapi, Deniz Göksedef, Suat Nail Ömeroğlu, Gökhan İpek, Ozan Onur Balkanay

Objective: Diffuse coronary artery disease remains a critical issue that heart surgeons continue to research in terms of treatment options. An alternative method applied during coronary bypass surgery to achieve complete revascularization is coronary artery endarterectomy. Since the reliability of this technique and its effects on mortality and morbidity are still debated in the literature. Our objective in conducting this study is to determine the mid-term patency rates in patients who underwent LAD endarterectomy and to explore its future applicability.

Materials and methods: This study reviewed 20 patients who underwent coronary endarterectomy during CABG in our clinic between January 2014 and December 2021. The data, including contrast imaging to check graft patency, were evaluated retrospectively by reviewing hospital archives and patient files. Patients without LAD endarterectomy were excluded from the study.

Results: LAD endarterectomy and patch-plasty were performed on all patients in the study. In 17 patients, the LIMA graft was anastomosed onto the patch applied to the LAD. It was observed that 12 of the grafts anastomosed to the LAD (60%) were patent during a mean follow-up period of 32.8 ± 25.9 months. The average 4-year survival rate was found to be 95%. Perioperative myocardial infarction occurred in 5 patients (25%). There was no need for high-dose inotropic support, IABP, or ECMO in the postoperative period.

Conclusion: Coronary artery endarterectomy should be considered a viable option for surgeons to achieve satisfactory revascularization in cases where suitable anastomosis sites on coronary arteries to ensure adequate outflow are not available. Our findings align closely with literature reports indicating that endarterectomy performed on the LAD, with LIMA used as the conduit, leads to promising outcomes.

目的:弥漫性冠状动脉疾病仍然是心脏外科医生在治疗选择方面继续研究的关键问题。在冠状动脉搭桥手术中实现完全血运重建的另一种方法是冠状动脉内膜切除术。由于该技术的可靠性及其对死亡率和发病率的影响在文献中仍有争议。我们进行这项研究的目的是确定LAD动脉内膜切除术患者的中期通畅率,并探讨其未来的适用性。材料和方法:本研究回顾了2014年1月至2021年12月在我诊所行冠状动脉内膜切除术的20例患者。通过查阅医院档案和患者档案,对资料进行回顾性评价,包括对比成像检查移植物通畅。未行LAD动脉内膜切除术的患者被排除在研究之外。结果:所有患者均行LAD动脉内膜切除术和补片成形术。在17例患者中,LIMA移植物与应用于LAD的贴片吻合。术后平均随访32.8±25.9个月,吻合LAD的移植物12例(60%)通畅。平均4年生存率为95%。围手术期发生心肌梗死5例(25%)。术后不需要大剂量肌力支持、IABP或ECMO。结论:在冠状动脉没有合适的吻合点以保证足够的流出的情况下,冠状动脉内膜切除术是外科医生实现满意血运重建的可行选择。我们的研究结果与文献报道密切一致,表明在LAD上进行动脉内膜切除术,将LIMA用作导管,会导致有希望的结果。
{"title":"Mid-term angiographic evaluation of LIMA-LAD anastomoses following LAD endarterectomy in coronary artery bypass grafting.","authors":"Farida Zahirova, Çiğdem Tel Üstünışık, Berk Arapi, Deniz Göksedef, Suat Nail Ömeroğlu, Gökhan İpek, Ozan Onur Balkanay","doi":"10.1186/s12872-024-04416-7","DOIUrl":"10.1186/s12872-024-04416-7","url":null,"abstract":"<p><strong>Objective: </strong>Diffuse coronary artery disease remains a critical issue that heart surgeons continue to research in terms of treatment options. An alternative method applied during coronary bypass surgery to achieve complete revascularization is coronary artery endarterectomy. Since the reliability of this technique and its effects on mortality and morbidity are still debated in the literature. Our objective in conducting this study is to determine the mid-term patency rates in patients who underwent LAD endarterectomy and to explore its future applicability.</p><p><strong>Materials and methods: </strong>This study reviewed 20 patients who underwent coronary endarterectomy during CABG in our clinic between January 2014 and December 2021. The data, including contrast imaging to check graft patency, were evaluated retrospectively by reviewing hospital archives and patient files. Patients without LAD endarterectomy were excluded from the study.</p><p><strong>Results: </strong>LAD endarterectomy and patch-plasty were performed on all patients in the study. In 17 patients, the LIMA graft was anastomosed onto the patch applied to the LAD. It was observed that 12 of the grafts anastomosed to the LAD (60%) were patent during a mean follow-up period of 32.8 ± 25.9 months. The average 4-year survival rate was found to be 95%. Perioperative myocardial infarction occurred in 5 patients (25%). There was no need for high-dose inotropic support, IABP, or ECMO in the postoperative period.</p><p><strong>Conclusion: </strong>Coronary artery endarterectomy should be considered a viable option for surgeons to achieve satisfactory revascularization in cases where suitable anastomosis sites on coronary arteries to ensure adequate outflow are not available. Our findings align closely with literature reports indicating that endarterectomy performed on the LAD, with LIMA used as the conduit, leads to promising outcomes.</p>","PeriodicalId":9195,"journal":{"name":"BMC Cardiovascular Disorders","volume":"24 1","pages":"726"},"PeriodicalIF":2.0,"publicationDate":"2024-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11660880/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142871253","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Heart failure patients' experiences of self-care neglect: a content analysis. 心衰患者自我护理忽视经历的内容分析。
IF 2 3区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-12-20 DOI: 10.1186/s12872-024-04347-3
Parisa Sadat Bahrodi, Azade Safa, Neda Mirbagher Ajorpaz, Fatemeh Sadat Izadi Avanji

Background: Heart failure is a chronic and common disorder worldwide. Patients with heart failure need self-care behaviors to manage their condition. Despite the importance of self-care in positive health outcomes, many patients with heart failure neglect their self-care behaviors. Therefore, the present study was conducted to explain heart failure patients' experiences of self-care neglect.

Methods: This qualitative study was conducted using conventional content analysis method. Participants included 15 patients with heart failure. Data were collected through semi-structured interviews and using purposive sampling method. Sampling continued until data saturation was reached. Data analysis was performed concurrently with data collection. Lincoln and Guba's four criteria were used to ensure the trustworthiness of the data. Data management was performed using MAXQDA version 24 software.

Results: The results were presented in the form of four main categories and 10 subcategories. In analyzing the data of the study, four main categories emerged in the participants' experiences: "false cultural beliefs in self-care", "weakening of mental-psychological power", "synergy of physical problems", and "inappropriate support".

Conclusion: The patients in their experiences of neglect in self-care pointed to false cultural beliefs in self-care, weakening of mental-psychological power, synergy of physical problems, and inappropriate support. Knowing the factors that influence self-care neglect and preventing their occurrence can improve self-care skills and prevent neglect-related side effects in patients with heart failure. Healthcare providers can help improve the health of these patients by developing interventions to mitigate these factors. It is suggested that future research be designed in the form of an intervention to reduce the effect of each of these factors.

Trial registration: This is a qualitative study and has not been registered in Iranian Registry of Clinical Trials.

背景:心力衰竭是世界范围内的一种慢性和常见疾病。心衰患者需要自我护理行为来控制病情。尽管自我照顾对积极的健康结果很重要,但许多心力衰竭患者忽视了他们的自我照顾行为。因此,本研究旨在解释心力衰竭患者的自我照顾忽视经历。方法:采用常规含量分析法进行定性研究。参与者包括15名心力衰竭患者。数据收集采用半结构化访谈和有目的的抽样方法。继续采样,直到达到数据饱和。数据分析与数据收集同时进行。使用Lincoln和Guba的四个标准来确保数据的可信度。使用MAXQDA 24版软件进行数据管理。结果:结果以4大类和10小类的形式呈现。在对研究数据的分析中,参与者的经历主要分为四类:“自我照顾的错误文化信念”、“心理力量的弱化”、“身体问题的协同作用”和“不适当的支持”。结论:患者自我护理被忽视主要表现为自我护理文化信念错误、心理-心理力量弱化、生理问题协同作用、支持不当等。了解影响自我护理忽视的因素并预防其发生,可以提高心衰患者的自我护理能力,预防忽视相关的不良反应。医疗保健提供者可以通过制定干预措施来减轻这些因素,从而帮助改善这些患者的健康状况。有人建议,未来的研究应以干预的形式设计,以减少这些因素的影响。试验注册:这是一项定性研究,尚未在伊朗临床试验注册中心注册。
{"title":"Heart failure patients' experiences of self-care neglect: a content analysis.","authors":"Parisa Sadat Bahrodi, Azade Safa, Neda Mirbagher Ajorpaz, Fatemeh Sadat Izadi Avanji","doi":"10.1186/s12872-024-04347-3","DOIUrl":"10.1186/s12872-024-04347-3","url":null,"abstract":"<p><strong>Background: </strong>Heart failure is a chronic and common disorder worldwide. Patients with heart failure need self-care behaviors to manage their condition. Despite the importance of self-care in positive health outcomes, many patients with heart failure neglect their self-care behaviors. Therefore, the present study was conducted to explain heart failure patients' experiences of self-care neglect.</p><p><strong>Methods: </strong>This qualitative study was conducted using conventional content analysis method. Participants included 15 patients with heart failure. Data were collected through semi-structured interviews and using purposive sampling method. Sampling continued until data saturation was reached. Data analysis was performed concurrently with data collection. Lincoln and Guba's four criteria were used to ensure the trustworthiness of the data. Data management was performed using MAXQDA version 24 software.</p><p><strong>Results: </strong>The results were presented in the form of four main categories and 10 subcategories. In analyzing the data of the study, four main categories emerged in the participants' experiences: \"false cultural beliefs in self-care\", \"weakening of mental-psychological power\", \"synergy of physical problems\", and \"inappropriate support\".</p><p><strong>Conclusion: </strong>The patients in their experiences of neglect in self-care pointed to false cultural beliefs in self-care, weakening of mental-psychological power, synergy of physical problems, and inappropriate support. Knowing the factors that influence self-care neglect and preventing their occurrence can improve self-care skills and prevent neglect-related side effects in patients with heart failure. Healthcare providers can help improve the health of these patients by developing interventions to mitigate these factors. It is suggested that future research be designed in the form of an intervention to reduce the effect of each of these factors.</p><p><strong>Trial registration: </strong>This is a qualitative study and has not been registered in Iranian Registry of Clinical Trials.</p>","PeriodicalId":9195,"journal":{"name":"BMC Cardiovascular Disorders","volume":"24 1","pages":"736"},"PeriodicalIF":2.0,"publicationDate":"2024-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11660939/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142871448","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
White blood cell-to-haemoglobin ratio as a predictor of 30-day mortality in ICU patients with pulmonary hypertension: a MIMIC-IV database study. 白细胞与血红蛋白比率作为ICU肺动脉高压患者30天死亡率的预测因子:一项MIMIC-IV数据库研究
IF 2 3区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-12-20 DOI: 10.1186/s12872-024-04396-8
Shuangping Li, Shenshen Huang, Yuxuan Feng, Yimin Mao

Background and objective: The white blood cell-to-haemoglobin ratio (WHR) is a comprehensive indicator of inflammation and anaemia status. However, the relationship between the WHR and the risk of 30-day mortality among intensive care unit (ICU) patients with pulmonary hypertension (PH) remains unclear. The purpose of this study was to investigate the association between the WHR and 30-day mortality in critically ill patients with PH.

Methods: Clinical data of patients with PH were extracted from the MIMIC-IV (2.2) database. Restricted cubic splines and logistic regression analysis were used to investigate the relationship between the WHR and 30-day mortality. Subgroup analysis was used to assess the robustness of the results.

Results: A total of 451 patients with PH were enrolled, with 78 (17.3%) dying within 30 days. Restricted cubic spline analysis revealed a linear relationship between the WHR and 30-day mortality. Logistic regression analysis revealed the WHR was an independent predictor for 30-day mortality in critically ill patients with PH (OR, 1.58; 95% CI, 1.05-2.37; P = 0.028). The AUC of the WHR was 0.646 (95% CI: 0.60-0.69).

Conclusions: A higher WHR was an independent predictor for 30-day mortality in critically ill patients with PH.

Clinical trial number: Not applicable.

背景和目的:白细胞与血红蛋白比率(WHR)是炎症和贫血状态的综合指标。然而,重症监护病房(ICU)肺动脉高压(PH)患者的WHR与30天死亡风险之间的关系尚不清楚。本研究的目的是探讨PH危重患者WHR与30天死亡率之间的关系。方法:从MIMIC-IV(2.2)数据库中提取PH患者的临床资料。采用限制三次样条和logistic回归分析探讨WHR与30天死亡率之间的关系。采用亚组分析来评估结果的稳健性。结果:共纳入451例PH患者,其中78例(17.3%)在30天内死亡。限制三次样条分析揭示了WHR与30天死亡率之间的线性关系。Logistic回归分析显示,WHR是PH危重患者30天死亡率的独立预测因子(OR, 1.58;95% ci, 1.05-2.37;p = 0.028)。WHR的AUC为0.646 (95% CI: 0.60-0.69)。结论:较高的WHR是ph危重患者30天死亡率的独立预测因子。
{"title":"White blood cell-to-haemoglobin ratio as a predictor of 30-day mortality in ICU patients with pulmonary hypertension: a MIMIC-IV database study.","authors":"Shuangping Li, Shenshen Huang, Yuxuan Feng, Yimin Mao","doi":"10.1186/s12872-024-04396-8","DOIUrl":"10.1186/s12872-024-04396-8","url":null,"abstract":"<p><strong>Background and objective: </strong>The white blood cell-to-haemoglobin ratio (WHR) is a comprehensive indicator of inflammation and anaemia status. However, the relationship between the WHR and the risk of 30-day mortality among intensive care unit (ICU) patients with pulmonary hypertension (PH) remains unclear. The purpose of this study was to investigate the association between the WHR and 30-day mortality in critically ill patients with PH.</p><p><strong>Methods: </strong>Clinical data of patients with PH were extracted from the MIMIC-IV (2.2) database. Restricted cubic splines and logistic regression analysis were used to investigate the relationship between the WHR and 30-day mortality. Subgroup analysis was used to assess the robustness of the results.</p><p><strong>Results: </strong>A total of 451 patients with PH were enrolled, with 78 (17.3%) dying within 30 days. Restricted cubic spline analysis revealed a linear relationship between the WHR and 30-day mortality. Logistic regression analysis revealed the WHR was an independent predictor for 30-day mortality in critically ill patients with PH (OR, 1.58; 95% CI, 1.05-2.37; P = 0.028). The AUC of the WHR was 0.646 (95% CI: 0.60-0.69).</p><p><strong>Conclusions: </strong>A higher WHR was an independent predictor for 30-day mortality in critically ill patients with PH.</p><p><strong>Clinical trial number: </strong>Not applicable.</p>","PeriodicalId":9195,"journal":{"name":"BMC Cardiovascular Disorders","volume":"24 1","pages":"729"},"PeriodicalIF":2.0,"publicationDate":"2024-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11660688/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142871302","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of a health management model based on the three-tier prevention and control system for cardiovascular and cerebrovascular diseases: a prospective cohort study in rural Central China (CENTRAL-HMM). 基于三级预防和控制体系的心脑血管疾病健康管理模式的效果:华中农村地区的前瞻性队列研究
IF 2 3区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-12-20 DOI: 10.1186/s12872-024-04431-8
Yongxia Wang, Jingjing Wei, Rui Yu, Xinlu Wang, Xingyuan Li, Guangcao Peng, Hongjie Ren, Jianru Wang, Qifei Zhao, Yanbo Zhang, Bin Li, Hongxin Guo, Yang Sun, Lijie Qiao, Jiabao Lei, Mingjun Zhu, Duolao Wang

Background: Cardiovascular and cerebrovascular diseases (CVDs) present a significant challenge in the realm of chronic disease management in China. The objective of this study is to assess the efficacy of a health management model rooted in a three-tier prevention and control system for CVDs.

Methods: From August 2020 to September 2020, this study enrolled 2033 CVDs patients from 105 villages across three townships in central China. All participants underwent a 12-month health management involving monitoring, risk assessment, health education, and interventions. The primary endpoint focused on recurrence and exacerbation, while secondary outcomes encompassed health economic indicators, awareness of prevention and control knowledge, risk factor, lifestyle behavior. Data analysis was conducted using generalized estimating equation models.

Results: After 1 year of follow-up, the odds of recurrence and exacerbation decreased significantly compared to the baseline [odds ratio (OR) 0.30, 95% confidence interval (CI): 0.26, 0.35], accompanied by reduced hospitalization frequency [mean difference (MD) -0.61, 95% CI: -0.66, -0.56] and a monthly average reduction in medication costs (MD, -69.80, 95% CI: -104.55, -35.05). Moreover, patients' awareness of CVDs prevention and treatment knowledge markedly improved (P < 0.01). Diastolic blood pressure, blood lipid and plasma glucose levels, anxiety and depression, lifestyle behavior all demonstrated significant enhancements from baseline levels (P < 0.01). Crucially, health management did not result in an increased abnormality rate of safety indicators.

Conclusions: The health management model, grounded in a three-level prevention and control system, showed potential applicability in reducing recurrence and exacerbation, easing healthcare economic burden, boosting awareness of prevention and treatment, and positively influencing risk factors. Additional multicenter and long-term studies are necessary to validate these findings and support broader implementation of this model.

Trial registration: Chinese Clinical Trial Registry (ChiCTR) ChiCTR2000032243 (24/04/2020) ( https://www.chictr.org.cn/showproj.html?proj=52395 ).

背景:心脑血管疾病(cvd)是中国慢性疾病管理领域的一个重大挑战。本研究的目的是评估基于心血管疾病三层预防和控制系统的健康管理模式的有效性。方法:2020年8月至2020年9月,在中国中部地区3个乡镇的105个村庄招募2033名心血管疾病患者。所有参与者都接受了为期12个月的健康管理,包括监测、风险评估、健康教育和干预措施。主要终点关注复发和恶化,次要终点包括健康经济指标、预防和控制知识意识、风险因素、生活方式行为。数据分析采用广义估计方程模型。结果:随访1年后,与基线相比,复发和恶化的几率显著降低[比值比(OR) 0.30, 95%可信区间(CI): 0.26, 0.35],住院次数减少[平均差值(MD) -0.61, 95% CI: -0.66, -0.56],每月平均用药费用减少(MD, -69.80, 95% CI: -104.55, -35.05)。结论:以三级防控体系为基础的健康管理模式在减少心血管疾病复发和加重、减轻医疗经济负担、提高预防和治疗意识、积极影响危险因素等方面具有潜在的适用性。需要更多的多中心和长期研究来验证这些发现,并支持该模型的更广泛实施。试验注册:中国临床试验注册中心(ChiCTR) ChiCTR2000032243 (24/04/2020) (https://www.chictr.org.cn/showproj.html?proj=52395)。
{"title":"Effect of a health management model based on the three-tier prevention and control system for cardiovascular and cerebrovascular diseases: a prospective cohort study in rural Central China (CENTRAL-HMM).","authors":"Yongxia Wang, Jingjing Wei, Rui Yu, Xinlu Wang, Xingyuan Li, Guangcao Peng, Hongjie Ren, Jianru Wang, Qifei Zhao, Yanbo Zhang, Bin Li, Hongxin Guo, Yang Sun, Lijie Qiao, Jiabao Lei, Mingjun Zhu, Duolao Wang","doi":"10.1186/s12872-024-04431-8","DOIUrl":"10.1186/s12872-024-04431-8","url":null,"abstract":"<p><strong>Background: </strong>Cardiovascular and cerebrovascular diseases (CVDs) present a significant challenge in the realm of chronic disease management in China. The objective of this study is to assess the efficacy of a health management model rooted in a three-tier prevention and control system for CVDs.</p><p><strong>Methods: </strong>From August 2020 to September 2020, this study enrolled 2033 CVDs patients from 105 villages across three townships in central China. All participants underwent a 12-month health management involving monitoring, risk assessment, health education, and interventions. The primary endpoint focused on recurrence and exacerbation, while secondary outcomes encompassed health economic indicators, awareness of prevention and control knowledge, risk factor, lifestyle behavior. Data analysis was conducted using generalized estimating equation models.</p><p><strong>Results: </strong>After 1 year of follow-up, the odds of recurrence and exacerbation decreased significantly compared to the baseline [odds ratio (OR) 0.30, 95% confidence interval (CI): 0.26, 0.35], accompanied by reduced hospitalization frequency [mean difference (MD) -0.61, 95% CI: -0.66, -0.56] and a monthly average reduction in medication costs (MD, -69.80, 95% CI: -104.55, -35.05). Moreover, patients' awareness of CVDs prevention and treatment knowledge markedly improved (P < 0.01). Diastolic blood pressure, blood lipid and plasma glucose levels, anxiety and depression, lifestyle behavior all demonstrated significant enhancements from baseline levels (P < 0.01). Crucially, health management did not result in an increased abnormality rate of safety indicators.</p><p><strong>Conclusions: </strong>The health management model, grounded in a three-level prevention and control system, showed potential applicability in reducing recurrence and exacerbation, easing healthcare economic burden, boosting awareness of prevention and treatment, and positively influencing risk factors. Additional multicenter and long-term studies are necessary to validate these findings and support broader implementation of this model.</p><p><strong>Trial registration: </strong>Chinese Clinical Trial Registry (ChiCTR) ChiCTR2000032243 (24/04/2020) ( https://www.chictr.org.cn/showproj.html?proj=52395 ).</p>","PeriodicalId":9195,"journal":{"name":"BMC Cardiovascular Disorders","volume":"24 1","pages":"732"},"PeriodicalIF":2.0,"publicationDate":"2024-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11661341/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142871446","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
BMC Cardiovascular Disorders
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1